Kane Biotech (KNE) Stock Chart & Stock Price History → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free KNE Stock Alerts C$0.15 +0.01 (+7.14%) (As of 05/17/2024 05:18 PM ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Kane Biotech Stock Price Performance5 Day Performance+15.38%1 Month Performance+15.38%3 Month Performance+36.36%6 Month Performance+150.00%Year-To-Date Performance+87.50%1 Year Performance+36.36% Receive KNE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. KNE Stock Chart for Saturday, May, 18, 2024 KNE Chart by TradingView Kane Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024C$0.14C$0.15+7.14%C$0.15C$0.1447,650 shsC$19.78 million05/16/2024C$0.14C$0.14+3.70%C$0.14C$0.142,035 shsC$18.46 million05/15/2024C$0.13C$0.14+8.00%C$0.14C$0.1433,000 shsC$17.80 million05/14/2024C$0.13C$0.13-3.85%C$0.13C$0.1321,000 shsC$16.48 million05/13/2024C$0.14C$0.13-7.14%C$0.14C$0.1338,850 shsC$17.14 million05/10/2024C$0.14C$0.14C$0.14C$0.141,000 shsC$18.46 million Get the Latest News and Ratings for KNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024C$0.14C$0.14C$0.14C$0.141,000 shsC$18.46 million05/08/2024C$0.14C$0.14+3.70%C$0.14C$0.142,005 shsC$18.46 million05/07/2024C$0.13C$0.14+3.85%C$0.14C$0.146,000 shsC$17.80 million05/06/2024C$0.13C$0.13C$0.14C$0.13138,000 shsC$17.14 million05/03/2024C$0.13C$0.13+4.00%C$0.14C$0.136,000 shsC$17.14 million05/02/2024C$0.13C$0.13C$0.13C$0.1322,000 shsC$16.48 million05/01/2024C$0.12C$0.13+4.17%C$0.13C$0.1322,000 shsC$16.48 million04/30/2024C$0.13C$0.12-7.69%C$0.14C$0.12173,500 shsC$15.82 million04/29/2024C$0.13C$0.13+4.00%C$0.14C$0.1326,200 shsC$17.14 million04/26/2024C$0.13C$0.13-3.85%C$0.14C$0.1331,500 shsC$16.48 million04/25/2024C$0.13C$0.13+4.00%C$0.13C$0.1312,000 shsC$17.14 million04/24/2024C$0.13C$0.13-3.85%C$0.14C$0.13150,900 shsC$16.48 million04/23/2024C$0.14C$0.13-7.14%C$0.15C$0.1327,500 shsC$17.14 million04/22/2024C$0.14C$0.14+3.70%C$0.14C$0.145,000 shsC$18.46 million04/19/2024C$0.13C$0.14+3.85%C$0.14C$0.13205,286 shsC$17.80 million04/18/2024C$0.13C$0.13+4.00%C$0.13C$0.131.05 million shsC$17.14 million04/17/2024C$0.14C$0.13-10.71%C$0.14C$0.132.07 million shsC$16.48 million04/16/2024C$0.14C$0.14+3.70%C$0.14C$0.1490,000 shsC$18.46 million04/15/2024C$0.13C$0.14+8.00%C$0.15C$0.121.94 million shsC$17.80 million04/12/2024C$0.14C$0.13-10.71%C$0.14C$0.11192,000 shsC$16.48 million04/11/2024C$0.15C$0.14-6.67%C$0.15C$0.13369,000 shsC$18.46 million04/10/2024C$0.16C$0.15-6.25%C$0.17C$0.14729,050 shsC$19.78 million04/09/2024C$0.15C$0.16+6.67%C$0.16C$0.15174,300 shsC$21.09 million04/08/2024C$0.15C$0.15+3.45%C$0.16C$0.14333,600 shsC$19.78 million04/05/2024C$0.13C$0.15+16.00%C$0.15C$0.12334,000 shsC$19.12 million04/04/2024C$0.12C$0.13+4.17%C$0.13C$0.1253,500 shsC$16.48 million04/03/2024C$0.12C$0.12+4.35%C$0.12C$0.10238,500 shsC$15.82 million04/02/2024C$0.12C$0.12C$0.12C$0.1162,250 shsC$15.16 million04/01/2024C$0.10C$0.12+15.00%C$0.12C$0.10201,171 shsC$15.16 million03/29/2024C$0.10C$0.10C$0.11C$0.10143,500 shsC$13.18 million03/28/2024C$0.10C$0.10C$0.11C$0.10143,500 shsC$13.18 million03/27/2024C$0.11C$0.10-4.76%C$0.10C$0.1022,000 shsC$13.18 million03/26/2024C$0.10C$0.11+5.00%C$0.11C$0.1055,500 shsC$13.84 million03/25/2024C$0.10C$0.10C$0.10C$0.104,000 shsC$13.18 millionI’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look.03/22/2024C$0.10C$0.10C$0.11C$0.1024,100 shsC$13.18 million03/21/2024C$0.11C$0.10-4.76%C$0.11C$0.1062,000 shsC$13.18 million03/20/2024C$0.11C$0.11C$0.11C$0.1063,100 shsC$13.84 million03/19/2024C$0.11C$0.11C$0.11C$0.109,000 shsC$13.84 million03/18/2024C$0.10C$0.11+5.00%C$0.11C$0.109,000 shsC$13.84 million03/15/2024C$0.10C$0.10+5.26%C$0.10C$0.101,000 shsC$13.18 million03/14/2024C$0.10C$0.10C$0.10C$0.0940,000 shsC$12.53 million03/13/2024C$0.10C$0.10-5.00%C$0.10C$0.0922,000 shsC$12.53 million03/12/2024C$0.10C$0.10+5.26%C$0.10C$0.101,000 shsC$13.18 million03/11/2024C$0.10C$0.10-5.00%C$0.10C$0.09130,050 shsC$12.53 million03/08/2024C$0.10C$0.10C$0.11C$0.1043,595 shsC$13.18 million03/07/2024C$0.11C$0.10-9.09%C$0.11C$0.0989,500 shsC$13.18 million03/06/2024C$0.11C$0.11C$0.11C$0.111,000 shsC$14.50 million03/05/2024C$0.11C$0.11C$0.11C$0.111,000 shsC$14.50 million03/04/2024C$0.11C$0.11C$0.11C$0.112,000 shsC$14.50 million03/01/2024C$0.11C$0.11+4.76%C$0.11C$0.111,000 shsC$14.50 million02/29/2024C$0.11C$0.11C$0.11C$0.114,380 shsC$13.84 million02/28/2024C$0.11C$0.11C$0.11C$0.111,000 shsC$13.84 million02/27/2024C$0.10C$0.11+5.00%C$0.11C$0.1011,500 shsC$13.84 million02/26/2024C$0.10C$0.10C$0.10C$0.09129,500 shsC$13.18 million02/23/2024C$0.10C$0.10+5.26%C$0.10C$0.1033,000 shsC$13.18 million02/22/2024C$0.11C$0.10-13.64%C$0.11C$0.09367,000 shsC$12.53 million02/21/2024C$0.11C$0.11+4.76%C$0.12C$0.1062,000 shsC$14.50 million02/20/2024C$0.11C$0.11-4.55%C$0.12C$0.1128,000 shsC$13.84 million02/19/2024C$0.11C$0.11C$0.12C$0.09127,500 shsC$14.50 million Related Companies: Resverlogix Stock Price Chart Antibe Therapeutics Stock Price Chart Sirona Biochem Stock Price Chart Aeterna Zentaris Stock Price Chart Ceapro Stock Price Chart Covalon Technologies Stock Price Chart Aptose Biosciences Stock Price Chart Innovotech Stock Price Chart Quest PharmaTech Stock Price Chart Devonian Health Group Stock Price Chart Receive KNE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kane Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:KNE) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kane Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
